新型双重内皮素受体拮抗剂马昔腾坦（Opsumit）的药理及临床概况 - Suppr

[Pharmacological and clinical profile of a novel dual endothelin receptor antagonist, macitentan (Opsumit)].

Takahashi Shuya, Horie Ritsuko, Yokoyama Yoshinari

Nihon Yakurigaku Zasshi. 2017;149(1):49-58. doi: 10.1254/fpj.149.49.

Abstract

摘要

Nihon Yakurigaku Zasshi. 2017;149(1):49-58. doi: 10.1254/fpj.149.49.

Am J Cardiovasc Drugs. 2016 Dec;16(6):453-460. doi: 10.1007/s40256-016-0188-x.

Eur J Pharmacol. 2017 Jun 5;804:111-116. doi: 10.1016/j.ejphar.2017.03.014. Epub 2017 Mar 11.

Chimia (Aarau). 2017 Aug 9;71(7):420-429. doi: 10.2533/chimia.2016.420.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466618823440. doi: 10.1177/1753466618823440.

Expert Rev Respir Med. 2014 Aug;8(4):393-9. doi: 10.1586/17476348.2014.937708. Epub 2014 Jul 6.

Med Lett Drugs Ther. 2014 Feb 17;56(1436):15-6.

Life Sci. 2014 Nov 24;118(2):333-9. doi: 10.1016/j.lfs.2014.02.018. Epub 2014 Feb 26.

Expert Opin Pharmacother. 2014 Dec;15(18):2733-9. doi: 10.1517/14656566.2014.980403. Epub 2014 Nov 11.

Drugs. 2014 Sep;74(13):1495-507. doi: 10.1007/s40265-014-0266-9.

BMJ Case Rep. 2019 Aug 12;12(8):e228295. doi: 10.1136/bcr-2018-228295.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。